Literature DB >> 33451043

Systemic Inflammation and the Breakdown of Intestinal Homeostasis Are Key Events in Chronic Spinal Cord Injury Patients.

David Diaz1,2,3, Elisa Lopez-Dolado1,4, Sergio Haro1,2, Jorge Monserrat1,2,3, Carlos Martinez-Alonso5, Dimitrios Balomeros5, Agustín Albillos1,2,3,6, Melchor Alvarez-Mon1,2,3,7.   

Abstract

Our aim was to investigate the subset distribution and function of circulating monocytes, proinflammatory cytokine levels, gut barrier damage, and bacterial translocation in chronic spinal cord injury (SCI) patients. Thus, 56 SCI patients and 28 healthy donors were studied. The levels of circulating CD14+highCD16-, CD14+highCD16+, and CD14+lowCD16+ monocytes, membrane TLR2, TLR4, and TLR9, phagocytic activity, ROS generation, and intracytoplasmic TNF-α, IL-1, IL-6, and IL-10 after lipopolysaccharide (LPS) stimulation were analyzed by polychromatic flow cytometry. Serum TNF-α, IL-1, IL-6 and IL-10 levels were measured by Luminex and LPS-binding protein (LBP), intestinal fatty acid-binding protein (I-FABP) and zonulin by ELISA. SCI patients had normal monocyte counts and subset distribution. CD14+highCD16- and CD14+highCD16+ monocytes exhibited decreased TLR4, normal TLR2 and increased TLR9 expression. CD14+highCD16- monocytes had increased LPS-induced TNF-α but normal IL-1, IL-6, and IL-10 production. Monocytes exhibited defective phagocytosis but normal ROS production. Patients had enhanced serum TNF-α and IL-6 levels, normal IL-1 and IL-10 levels, and increased circulating LBP, I-FABP, and zonulin levels. Chronic SCI patients displayed impaired circulating monocyte function. These patients exhibited a systemic proinflammatory state characterized by enhanced serum TNF-α and IL-6 levels. These patients also had increased bacterial translocation and gut barrier damage.

Entities:  

Keywords:  bacterial translocation; chronic spinal cord injury; cytokines; gut barrier damage; monocyte; systemic inflammation

Mesh:

Substances:

Year:  2021        PMID: 33451043      PMCID: PMC7828526          DOI: 10.3390/ijms22020744

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  72 in total

1.  The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population.

Authors:  Manuela Rossol; Stephan Kraus; Matthias Pierer; Christoph Baerwald; Ulf Wagner
Journal:  Arthritis Rheum       Date:  2012-03

2.  CD14(hi)HLA-DR(dim) macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease.

Authors:  Susanne Thiesen; Sabina Janciauskiene; Heli Uronen-Hansson; William Agace; Carl-Magnus Högerkorp; Pieter Spee; Katarina Håkansson; Olof Grip
Journal:  J Leukoc Biol       Date:  2013-11-08       Impact factor: 4.962

3.  CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.

Authors:  Kyrill S Rogacev; Sarah Seiler; Adam M Zawada; Birgit Reichart; Esther Herath; Daniel Roth; Christof Ulrich; Danilo Fliser; Gunnar H Heine
Journal:  Eur Heart J       Date:  2010-10-12       Impact factor: 29.983

Review 4.  Modulating inflammatory cell responses to spinal cord injury: all in good time.

Authors:  Amy L Bowes; Ping K Yip
Journal:  J Neurotrauma       Date:  2014-09-08       Impact factor: 5.269

5.  Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury.

Authors:  Andrew L Davies; Keith C Hayes; Gregory A Dekaban
Journal:  Arch Phys Med Rehabil       Date:  2007-11       Impact factor: 3.966

6.  Toll-like receptor 4 plays a role in macrophage phagocytosis during peritoneal sepsis.

Authors:  Rahul J Anand; Jeffrey W Kohler; Jaime A Cavallo; Jun Li; Theresa Dubowski; David J Hackam
Journal:  J Pediatr Surg       Date:  2007-06       Impact factor: 2.545

7.  Inflammatory response to Escherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host.

Authors:  Rajeev Chaudhry; Ramiro J Madden-Fuentes; Tara K Ortiz; Zarine Balsara; Yuping Tang; Unwanaobong Nseyo; John S Wiener; Sherry S Ross; Patrick C Seed
Journal:  J Urol       Date:  2013-12-14       Impact factor: 7.450

8.  Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors.

Authors:  Jérôme Cros; Nicolas Cagnard; Kevin Woollard; Natacha Patey; Shen-Ying Zhang; Brigitte Senechal; Anne Puel; Subhra K Biswas; Despina Moshous; Capucine Picard; Jean-Philippe Jais; David D'Cruz; Jean-Laurent Casanova; Céline Trouillet; Fréderic Geissmann
Journal:  Immunity       Date:  2010-09-09       Impact factor: 31.745

9.  Modulation of monocytes in septic patients: preserved phagocytic activity, increased ROS and NO generation, and decreased production of inflammatory cytokines.

Authors:  Sidnéia S Santos; Amanda M Carmo; Milena K C Brunialti; Flavia R Machado; Luciano C Azevedo; Murillo Assunção; Sílvia C Trevelin; Fernando Q Cunha; Reinaldo Salomao
Journal:  Intensive Care Med Exp       Date:  2016-02-16

10.  Gut dysbiosis impairs recovery after spinal cord injury.

Authors:  Kristina A Kigerl; Jodie C E Hall; Lingling Wang; Xiaokui Mo; Zhongtang Yu; Phillip G Popovich
Journal:  J Exp Med       Date:  2016-10-17       Impact factor: 14.307

View more
  4 in total

1.  Spinal Cord Injury Impairs Lung Immunity in Mice.

Authors:  Katherine A Mifflin; Faith H Brennan; Zhen Guan; Kristina A Kigerl; Angela R Filous; Xiaokui Mo; Jan M Schwab; Phillip G Popovich
Journal:  J Immunol       Date:  2022-06-13       Impact factor: 5.426

Review 2.  The Repression of the HMGB1-TLR4-NF-κB Signaling Pathway by Safflower Yellow May Improve Spinal Cord Injury.

Authors:  Lu Wang; Benson O A Botchway; Xuehong Liu
Journal:  Front Neurosci       Date:  2021-12-24       Impact factor: 4.677

3.  Inflammation in Health and Disease: New Insights and Therapeutic Avenues.

Authors:  Morena Scotece; Javier Conde-Aranda
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

4.  Mechanism of Anti-Inflammatory and Antibacterial Effects of QingXiaoWuWei Decoction Based on Network Pharmacology, Molecular Docking and In Vitro Experiments.

Authors:  Qian Zhang; Xue Li; Jun Li; Yuxia Hu; Jing Liu; Fang Wang; Wei Zhang; Fuhou Chang
Journal:  Front Pharmacol       Date:  2021-07-15       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.